Hillas Georgios, Perlikos Fotis, Tsiligianni Ioanna, Tzanakis Nikolaos
Department of Critical Care and Pulmonary Services, University of Athens Medical School, Evangelismos Hospital, Athens, Greece.
Department of Thoracic Medicine, University Hospital of Heraklion, Medical School, University of Crete, Crete, Greece ; Department of General Practice, University Medical Centre of Groningen, Groningen, The Netherlands.
Int J Chron Obstruct Pulmon Dis. 2015 Jan 7;10:95-109. doi: 10.2147/COPD.S54473. eCollection 2015.
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Age and smoking are common risk factors for COPD and other illnesses, often leading COPD patients to demonstrate multiple coexisting comorbidities. COPD exacerbations and comorbidities contribute to the overall severity in individual patients. Clinical trials investigating the treatment of COPD routinely exclude patients with multiple comorbidities or advanced age. Clinical practice guidelines for a specific disease do not usually address comorbidities in their recommendations. However, the management and the medical intervention in COPD patients with comorbidities need a holistic approach that is not clearly established worldwide. This holistic approach should include the specific burden of each comorbidity in the COPD severity classification scale. Further, the pharmacological and nonpharmacological management should also include optimal interventions and risk factor modifications simultaneously for all diseases. All health care specialists in COPD management need to work together with professionals specialized in the management of the other major chronic diseases in order to provide a multidisciplinary approach to COPD patients with multiple diseases. In this review, we focus on the major comorbidities that affect COPD patients. We present an overview of the problems faced, the reasons and risk factors for the most commonly encountered comorbidities, and the burden on health care costs. We also provide a rationale for approaching the therapeutic options of the COPD patient afflicted by comorbidity.
慢性阻塞性肺疾病(COPD)是全球发病和死亡的主要原因。年龄和吸烟是COPD及其他疾病的常见风险因素,常导致COPD患者出现多种并存的合并症。COPD急性加重和合并症会加重个体患者的整体病情严重程度。研究COPD治疗的临床试验通常会排除患有多种合并症或高龄的患者。针对特定疾病的临床实践指南在其推荐中通常不会涉及合并症。然而,对于患有合并症的COPD患者的管理和医学干预需要一种全球尚未明确确立的整体方法。这种整体方法应包括在COPD严重程度分类量表中每种合并症的具体负担。此外,药物和非药物管理还应同时针对所有疾病进行最佳干预和风险因素调整。所有参与COPD管理的医疗保健专家需要与其他主要慢性病管理方面的专业人员合作,以便为患有多种疾病的COPD患者提供多学科方法。在本综述中,我们重点关注影响COPD患者的主要合并症。我们概述了所面临的问题、最常见合并症的原因和风险因素以及对医疗保健成本的负担。我们还为处理患有合并症的COPD患者的治疗选择提供了理论依据。